These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19098487)

  • 1. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
    Massanella M; Puigdomènech I; Cabrera C; Fernandez-Figueras MT; Aucher A; Gaibelet G; Hudrisier D; García E; Bofill M; Clotet B; Blanco J
    AIDS; 2009 Jan; 23(2):183-8. PubMed ID: 19098487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
    Sánchez-Palomino S; Massanella M; Carrillo J; García A; García F; González N; Merino A; Alcamí J; Bofill M; Yuste E; Gatell JM; Clotet B; Blanco J
    Vaccine; 2011 Jul; 29(32):5250-9. PubMed ID: 21609746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission.
    Bosch B; Grigorov B; Senserrich J; Clotet B; Darlix JL; Muriaux D; Este JA
    Antiviral Res; 2008 Nov; 80(2):185-93. PubMed ID: 18602423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection.
    Clotet-Codina I; Bosch B; Senserrich J; Fernández-Figueras MT; Peña R; Ballana E; Bofill M; Clotet B; Esté JA
    Antiviral Res; 2009 Jul; 83(1):94-8. PubMed ID: 19501262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.
    Scherer EM; Zwick MB; Teyton L; Burton DR
    AIDS; 2007 Oct; 21(16):2131-9. PubMed ID: 18090039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inefficient human immunodeficiency virus replication in mobile lymphocytes.
    Sourisseau M; Sol-Foulon N; Porrot F; Blanchet F; Schwartz O
    J Virol; 2007 Jan; 81(2):1000-12. PubMed ID: 17079292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    Virology; 2005 Mar; 333(1):102-13. PubMed ID: 15708596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation.
    Martinez V; Diemert MC; Braibant M; Potard V; Charuel JL; Barin F; Costagliola D; Caumes E; Clauvel JP; Autran B; Musset L;
    Clin Infect Dis; 2009 Jan; 48(1):123-32. PubMed ID: 19035778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.
    Blish CA; Nedellec R; Mandaliya K; Mosier DE; Overbaugh J
    AIDS; 2007 Mar; 21(6):693-702. PubMed ID: 17413690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.
    Lekkerkerker AN; Ludwig IS; van Vliet SJ; van Kooyk Y; Geijtenbeek TB
    Virology; 2004 Nov; 329(2):465-76. PubMed ID: 15518824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
    Debre P; Costagliola D; Legrand R; Vieillard V
    Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 15. Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.
    Bunnik EM; Lobbrecht MS; van Nuenen AC; Schuitemaker H
    Virology; 2010 Feb; 397(1):224-30. PubMed ID: 19945135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope.
    Molina L; Grimaldi M; Robert-Hebmann V; Espert L; Varbanov M; Devaux C; Granier C; Biard-Piechaczyk M
    Proteomics; 2007 Sep; 7(17):3116-30. PubMed ID: 17676665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
    Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
    Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration.
    Schmidt B; Ashlock BM; Foster H; Fujimura SH; Levy JA
    Virology; 2005 Dec; 343(2):256-66. PubMed ID: 16278001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K; Zhang Y; Xu J; Yu Q; Tam JP
    Biopolymers; 2008; 90(3):320-9. PubMed ID: 18338371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.
    Cicala C; Arthos J; Censoplano N; Cruz C; Chung E; Martinelli E; Lempicki RA; Natarajan V; VanRyk D; Daucher M; Fauci AS
    Virology; 2006 Feb; 345(1):105-14. PubMed ID: 16260021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.